A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase

A Shannon, V Fattorini, B Sama, B Selisko… - Nature …, 2022 - nature.com
The guanosine analog AT-527 represents a promising candidate against Severe Acute
Respiratory Syndrome coronavirus type 2 (SARS-CoV-2). AT-527 recently entered phase III …

New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'‐5'exoribonucleolytic activity on SARS‐CoV‐2

M Saramago, C Bárria, VG Costa, CS Souza… - The FEBS …, 2021 - Wiley Online Library
SARS‐CoV‐2 virus has triggered a global pandemic with devastating consequences. The
understanding of fundamental aspects of this virus is of extreme importance. In this work, we …

The SARS-CoV-2 RNA polymerase is a viral RNA capping enzyme

AP Walker, H Fan, JR Keown, ML Knight… - Nucleic acids …, 2021 - academic.oup.com
SARS-CoV-2 is a positive-sense RNA virus responsible for the Coronavirus Disease 2019
(COVID-19) pandemic, which continues to cause significant morbidity, mortality and …

Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin

W Yin, X Luan, Z Li, Z Zhou, Q Wang, M Gao… - Nature structural & …, 2021 - nature.com
The COVID-19 pandemic caused by nonstop infections of SARS-CoV-2 has continued to
ravage many countries worldwide. Here we report that suramin, a 100-year-old drug, is a …

NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain

B Wang, D Svetlov, I Artsimovitch - Nucleic acids research, 2021 - academic.oup.com
The catalytic subunit of SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) contains
two active sites that catalyze nucleotidyl-monophosphate transfer (NMPylation). Mechanistic …

Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target

Y Gao, L Yan, Y Huang, F Liu, Y Zhao, L Cao, T Wang… - BioRxiv, 2020 - biorxiv.org
Abstract A novel coronavirus (2019-nCoV) outbreak has caused a global pandemic resulting
in tens of thousands of infections and thousands of deaths worldwide. The RNA-dependent …

[HTML][HTML] A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors

L Yan, Y Huang, J Ge, Z Liu, P Lu, B Huang, S Gao… - Cell, 2022 - cell.com
Decoration of cap on viral RNA plays essential roles in SARS-CoV-2 proliferation. Here, we
report a mechanism for SARS-CoV-2 RNA capping and document structural details at …

A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19

S Jockusch, C Tao, X Li, TK Anderson, M Chien… - Antiviral research, 2020 - Elsevier
Abstract SARS-CoV-2, a member of the coronavirus family, is responsible for the current
COVID-19 worldwide pandemic. We previously demonstrated that five nucleotide analogues …

Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP

M Biswal, S Diggs, D Xu, N Khudaverdyan… - Nucleic acids …, 2021 - academic.oup.com
Replication of the∼ 30 kb-long coronavirus genome is mediated by a complex of non-
structural proteins (NSP), in which NSP7 and NSP8 play a critical role in regulating the RNA …

Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN

NH Moeller, K Shi, Ö Demir, C Belica… - Proceedings of the …, 2022 - National Acad Sciences
High-fidelity replication of the large RNA genome of coronaviruses (CoVs) is mediated by a
3′-to-5′ exoribonuclease (ExoN) in nonstructural protein 14 (nsp14), which excises …